Elanco Animal Health (ELAN) Operating Income (2017 - 2026)
Elanco Animal Health (ELAN) posted Operating Income of $291.0 million for Q1 2026, up 761.36% sequentially from -$44.0 million in Q4 2025, and up 21.25% YoY from $240.0 million in Q1 2025.
Elanco Animal Health (ELAN) Operating Income (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Operating Income for 10 years, with the latest figure at $291.0 million in Q1 2026.
- Quarterly Operating Income rose 21.25% year-over-year to $291.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $609.0 million (up 178.89% YoY) and the FY2025 annual result came in at $558.0 million, up 136.83% from the prior year.
- Operating Income improved to $291.0 million in Q1 2026 per ELAN's latest filing, from -$44.0 million in the prior quarter.
- Over five years, Operating Income peaked at $291.0 million in Q1 2026 and troughed at -$1.6 billion in Q3 2023.
- A 5-year average of -$339.8 million and a median of -$498.0 million in 2022 frame the typical range for Operating Income.
- The sharpest annual moves came in 2023 and 2025: Operating Income slumped 206.98% in 2023, then jumped 147.71% in 2025.
- Over 5 years, Operating Income stood at -$537.0 million in 2022, then declined by 19.74% to -$643.0 million in 2023, then gained by 14.15% to -$552.0 million in 2024, then soared by 92.03% to -$44.0 million in 2025, then surged by 761.36% to $291.0 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $291.0 million, -$44.0 million, and $142.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 18.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 248.00 Mn |
| Mar 31, 2026 | 291.00 Mn |
| Dec 31, 2025 | -44.00 Mn |
| Sep 30, 2025 | 142.00 Mn |
| Jun 30, 2025 | 220.00 Mn |
| Mar 31, 2025 | 240.00 Mn |
| Dec 31, 2024 | -552.00 Mn |
| Sep 30, 2024 | 67.00 Mn |
| Jun 30, 2024 | -527.00 Mn |
| Mar 31, 2024 | -503.00 Mn |
| Dec 31, 2023 | -643.00 Mn |
| Sep 30, 2023 | -1.58 Bn |
| Jun 30, 2023 | -513.00 Mn |
| Mar 31, 2023 | -386.00 Mn |
| Dec 31, 2022 | -537.00 Mn |
| Sep 30, 2022 | -516.00 Mn |
| Jun 30, 2022 | -498.00 Mn |
| Mar 31, 2022 | -434.00 Mn |
| Dec 31, 2021 | -635.00 Mn |
| Sep 30, 2021 | -632.00 Mn |